v3.26.1
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Balance at Beginning at Dec. 31, 2024 $ 287,064 $ 16 $ 1,234,207 $ 62 $ (947,221)
Balance at Beginning (in Shares) at Dec. 31, 2024   161,710      
Forfeiture of unvested restricted common stock, shares   (231)      
Vesting of restricted stock units, shares   269      
Vesting of common stock subject to repurchase 33   33    
Unrealized loss on marketable debt securities (65)     (65)  
Stock-based compensation 9,324   9,324    
Net loss (67,992)       (67,992)
Balance at Ending at Mar. 31, 2025 228,364 $ 16 1,243,564 (3) (1,015,213)
Balance at Ending (in Shares) at Mar. 31, 2025   161,748      
Balance at Beginning at Dec. 31, 2024 287,064 $ 16 1,234,207 62 (947,221)
Balance at Beginning (in Shares) at Dec. 31, 2024   161,710      
Unrealized loss on marketable debt securities (77)        
Net loss (120,723)        
Balance at Ending at Jun. 30, 2025 182,879 $ 16 1,250,822 (15) (1,067,944)
Balance at Ending (in Shares) at Jun. 30, 2025   161,947      
Balance at Beginning at Mar. 31, 2025 228,364 $ 16 1,243,564 (3) (1,015,213)
Balance at Beginning (in Shares) at Mar. 31, 2025   161,748      
Issuance of common stock under employee stock purchase plan, shares   97      
Issuance of common stock under employee stock purchase plan 59   59    
Vesting of restricted stock units, shares   102      
Vesting of common stock subject to repurchase 34   34    
Unrealized loss on marketable debt securities (12)     (12)  
Stock-based compensation 7,165   7,165    
Net loss (52,731)       (52,731)
Balance at Ending at Jun. 30, 2025 182,879 $ 16 1,250,822 $ (15) (1,067,944)
Balance at Ending (in Shares) at Jun. 30, 2025   161,947      
Balance at Beginning at Dec. 31, 2025 103,871 $ 17 1,288,003   (1,184,149)
Balance at Beginning (in Shares) at Dec. 31, 2025   174,260      
Issuance of common stock through at-the-market transactions net of offering costs, shares   5,343      
Issuance of common stock through at-the-market transactions net of offering costs 10,875 $ 1 10,874    
Vesting of restricted stock units, shares   218      
Issuance of common stock upon conversion of convertible debt, shares   2,336      
Issuance of common stock upon conversion of convertible debt 1,987   1,987    
Stock-based compensation 7,405   7,405    
Net loss (53,458)       (53,458)
Balance at Ending at Mar. 31, 2026 70,680 $ 18 1,308,269   (1,237,607)
Balance at Ending (in Shares) at Mar. 31, 2026   182,157      
Balance at Beginning at Dec. 31, 2025 103,871 $ 17 1,288,003   (1,184,149)
Balance at Beginning (in Shares) at Dec. 31, 2025   174,260      
Unrealized loss on marketable debt securities 0        
Net loss (96,540)        
Balance at Ending at Jun. 30, 2026 44,519 $ 19 1,325,189   (1,280,689)
Balance at Ending (in Shares) at Jun. 30, 2026   186,851      
Balance at Beginning at Mar. 31, 2026 70,680 $ 18 1,308,269   (1,237,607)
Balance at Beginning (in Shares) at Mar. 31, 2026   182,157      
Issuance of common stock through at-the-market transactions net of offering costs, shares   4,542      
Issuance of common stock through at-the-market transactions net of offering costs 9,498 $ 1 9,497    
Issuance of common stock under employee stock purchase plan, shares   152      
Issuance of common stock under employee stock purchase plan 239   239    
Unrealized loss on marketable debt securities 0        
Stock-based compensation 7,184   7,184    
Net loss (43,082)       (43,082)
Balance at Ending at Jun. 30, 2026 $ 44,519 $ 19 $ 1,325,189   $ (1,280,689)
Balance at Ending (in Shares) at Jun. 30, 2026   186,851